Executive committee members
Ali Andalibi, Ph.D. (Chair)
Professor and Senior Associate Dean, College of Science, George Mason University
Inflammatory diseases – genetics and drug discovery. More →
John D. Catravas, Ph.D., FAPS, FAHA, FACCP
Sentara Chair, Frank Reidy Research Center for Bioelectrics; Professor, School for Medical, Diagnostic &Translational Sciences, College of Health Sciences, Old Dominion University. Adjunct Professor, Departments of Medicine (Pulmonary & Critical Care) and Physiological Sciences, Eastern Virginia Medical School.
Antidotes against chemically-induced acute (ALI/ARDS) and chronic (Fibrosis) lung injury. Mechanisms and treatment of COVID-19 associated ARDS.
Kathryn Cole, Ph.D.
Associate Professor, Department of Molecular Biology and Chemistry, Christopher Newport Univ.
Research in my lab uses molecular modeling and protein crystallography to study the structure-function relationships of polysaccharide deacetylases and histone deacetylases for the development of antibacterial and anticancer therapeutics, respectively. More →
Umesh Desai, Ph.D.
Professor, Institute for Structural Biology, Drug Discovery & Development, Virginia Commonwealth University
Glycosaminoglycans and mimetics as modulators of coagulation, cancer, inflammation, emphysema and viral infection
Marion Ehrich, R.Ph., Ph.D., DABT, ATS
Professor of Pharmacology/Toxicology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, and Virginia Tech School of Medicine
Nick Farrell, Ph.D.
Professor of Chemistry, Virginia Commonwealth University
Platinum, anticancer drugs, zinc fingers, metalloglycomics. More →
Paul B. Fisher, M.Ph., Ph.D., FNAI
Professor and Chair, Department of Human and Molecular Genetics, VCU Director, VCU Institute of Molecular Medicine
Molecular determinants of cancer progression and metastasis, viral-based therapy of cancer (Cancer Terminator Viruses) and small molecule inhibitors of metastasis More →
John Lazo, Ph.D.
Harrison Distinguished Professor Emeritus, Departments of Pharmacology and Chemistry, and CSO of KeViRx, University of Virginia
Pharmacology, Chemical-Biology, Phosphatases, Cancer, Alzheimer’s disease. More →
Mikell Paige, Ph.D.
Associate Professor, Department of Chemistry and Biochemistry, George Mason University
Drug Discovery, Pulmonary Inflammation, Fibrosis, Traumatic Brain Injury, Medicinal Chemistry, Organic Synthesis, Enzymology, Protein Chemistry
Webster Santos, Ph.D.
Professor, Department of Chemistry, Virginia Tech
Drug Discovery, Mitochondrial Uncouplers, S1P modulators, Metabolic Diseases, Multiple Sclerosis, Kidney Diseases
Mohamed N. Seleem, Ph.D.
Tyler and Frances Young Chair in Bacteriology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech
Antibacterial and Antifungal Drug Discovery
Elizabeth Sharlow, Ph.D.
Associate Professor of Research, Department of Pharmacology; Co-Director, Fiske Drug Discovery Laboratory, University of Virginia
Chemical Biology, Phosphatases, Cancer, High Throughput Screening, Assay Development
Cliff Stains, Ph.D.
Associate Professor, Department of Chemistry, University of Virginia
Development of tumor site-activated small molecules
Douglas Young, Ph.D
Cornelia Brackenridge Talbot Term Distinguished Associate Professor of Chemistry, William & Mary
Development of chemical tools to address biological questions and diseases
Yan Zhang, Ph.D.
Professor, School of Pharmacy, Department of Medicinal Chemistry, Virginia Commonwealth University
Drug design and development